These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Rapid and effective conversion of 6-keto-prostaglandin F1 alpha to 6,15-diketo-13, 14-dihydro-prostaglandin F1 alpha-immunoreactive material in vivo.
    Author: Förstermann U, Neufang B, Hertting G.
    Journal: Prostaglandins Leukot Med; 1982 Sep; 9(3):277-84. PubMed ID: 6752956.
    Abstract:
    Pentobarbitone-anaesthetized cats were injected i.v. with equal doses of prostacyclin and 6-keto-PGF1 alpha. Subsequently the time course of plasma levels of 6-keto-PGF1 alpha-immunoreactivity (i.r.) and 6,15-diketo-13, 14-dihydro-PGFi alpha-i.r. was determined in arterial blood by specific radioimmunoassays. Injection of both prostacyclin and 6-keto-PGF1 alpha resulted in short lasting peaks of 6-keto-PGF1 alpha-i.r. with maxima after 1 min, which rapidly declined. After injection of prostacyclin plasma 6,15-diketo-13, 14-dihydro-PGF1 alpha-i.r. increased to about one third of the height of the 6-keto-PGF1 alpha-peak and the maximum was reached after 6 min. On the other hand after administration of the same dose of 6-keto-PGFi alpha 6,15-diketo-13, 14-dihydro-PGF1 alpha-i.r. rose to about the same level as the 6-keto-PGF1 alpha-immunoreactive peak and the maximum was already attained after 2 min. When 6,15-diketo-13, 14-dihydro-PGF1 alpha itself was injected no increase in 6-keto-PGF1 alpha-i.r. was seen, whereas the 6,15-diketo-13, 14-dihydro-PGFi alpha-i.r. markedly increased, reaching its maximum after 1 min. These data indicate that in the cat in vivo 6-keto-PGF1 alpha can be rapidly metabolized to a 6,15-diketo-13, 14-dihydro-PGF1 alpha-like compound. The smaller conversion of prostacyclin as compared to 6-keto-PGF1 alpha could be explained by differences in compartmentalization of the two prostaglandins.
    [Abstract] [Full Text] [Related] [New Search]